The TLR4-MyD88-dependent signaling pathway can activate transcription factors such as NFκB and activatorprotein-1 (AP-1), before activating related immune cells to play the role of immunosuppression and promote the development of tumor disease (92). The gene discussed is TLR4; the disease is neoplasm.